Herpes is one of the most problematic and serious diseases that can be transmitted by sexual activity. This disease can spread easily when a person infected by the herpes virus makes sexual contact with someone who is not infected. The symptoms of this condition are quite subtle in many cases. A new herpes vaccine is currently in trial phases and this will help protect uninfected individuals from this condition.

This common viral infection can spread through skin contact. The two viruses that result in herpes include herpes simplex type one (HSV-1) and herpes simplex type two (HSV-2). The first type causes fever, blisters in the mouth region or the face along with cold sores. The second virus causes genital herpes and has a wide range of symptoms that include flu like symptoms along with painful sores.

There is no definite treatment that can help eliminate this virus. There is however a promising herpes vaccine that can protect women from genital herpes. This vaccine has passed the initial stages of testing and now is being tested in the final phase.

The herpes vaccine has a tremendous potential to provide relief from the physical discomfort along with the emotional distress that is brought on by herpes. If this vaccine is proved to be effective it will help in preventing genital herpes among women and will also reduce the risk of this infection among people in general. This vaccine consists of a protein that is identified and found on the surface of the virus responsible for causing this condition.

Research indicates that the body identifies this protein after which antibodies are made that protect individuals from the herpes virus. So basically the vaccine tricks the body into believing that exposure to the herpes virus has occurred. If exposure to the virus happens in the future then the antibodies get rid of the virus. Since the herpes vaccine does not use any weakened form of the live virus there is no possibility of contracting the disease through the vaccine.

Previous research and studies indicate that the vaccine used in investigational stages resulted in around 74 percent reduction in this disease. The herpes vaccine does not protect men and it is not really understood why that is the case. This vaccine can be of particular help as it can protect people from the daily problems that this disease causes. Research indicates that this vaccine will be made available for use in a time period of around 3 to 4 years.